Part 3: Regulatory dynamics and research trends
Insights from Goldman Sachs and Parexel: Decoding Healthcare's Future: Investment, Clinical Research, and Regulatory Dynamics
FDA had a record year for approvals in 2023 and continues to create regulatory pathways. The advice for biopharma: keep pushing regulatory boundaries. And drug development strategies should emphasize cross-pollination across therapeutic areas. Hear more from Amy McKee, MD, Chief Medical Officer and Global Head of Oncology Center of Excellence at Parexel.
For more expert insights, visit https://www.parexel.com/insights
January 2024, San Francisco CA
Disclaimer: The views and opinions that the panelists express are their own and are for informational purposes only. They do not constitute a recommendation by Goldman Sachs Asset Management for you to take any action.